Bladder preservation in complicated invasive urothelial carcinoma following treatment with cisplatin/gemcitabine plus tislelizumab: A case report

doi:10.12998/wjcc.v11.i5.1165

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2769)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

138

WORD

HTML

1190

Figures (1-5)

279

Tables (1-1)

210

Sum=1852

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

175

Download

271

Sum=446

Publishing Process of This Article

Item

Count

Browse

114

Download

357

Sum=471

Feb 16, 2023 (publication date) through May 18, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Feb 16, 2023; 11(5): 1165-1174
Published online Feb 16, 2023. doi: 10.12998/wjcc.v11.i5.1165

Table 1 The somatic mutations

Gene	Mutation	Abundance
ERBB2	p.S310F	3.62%
RB1	p.F404Lfs6*	10.42%
ARID1A	p.S733*	11.14%
TERT	c.-124C>T	14.83%
TP53	p.R282W	3.70%
TP53	p.P152T	24.48%

Citation: Yang R, Chen JX, Luo SH, Chen TT, Chen LW, Huang B. Bladder preservation in complicated invasive urothelial carcinoma following treatment with cisplatin/gemcitabine plus tislelizumab: A case report. World J Clin Cases 2023; 11(5): 1165-1174
URL: https://www.wjgnet.com/2307-8960/full/v11/i5/1165.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i5.1165